Evaluation of lamina cribrosa and peripapillary vascular density in thyroid orbitopathy and effect of intravenous methylprednisolone therapy

Can J Ophthalmol. 2024 Oct;59(5):e489-e495. doi: 10.1016/j.jcjo.2023.11.003. Epub 2023 Dec 11.

Abstract

Objective: To evaluate optic nerve head changes in patients with thyroid orbitopathy (TO) and investigate the effects of intravenous methylprednisolone (IV MTP) on these changes.

Methods: Eighty-two eyes of 41 patients with TO with and without dysthyroid optic neuropathy (DON) and 40 eyes of 40 healthy control subjects were included in the study. Lamina cribrosa thickness (LCT) and depth (LCD) measurements, peripapillary retinal nerve fibre layer thickness (RNFLT), and radial peripapillary capillary vascular density were measured using optical coherence tomography and optical coherence tomography angiography. Visual field examination and proptosis were evaluated. Patients with DON and active non-DON received IV MTP for 12 weeks, and the effect of this treatment was evaluated.

Results: Peripapillary vascular density decreased in patients with DON compared with the other groups (p < 0.001 for all); there was no difference in the total, superior hemi-sector, and inferior hemi-sector of the RNFLT between the groups. LCT was decreased in the TO group (p < 0.001). After IV MTP treatment, the LCT and best-corrected visual acuity were increased. Thyroid-stimulating hormone receptor antibody levels, intraocular pressure, the superior hemi-sector of the RNFLT, and proptosis were decreased compared with the control subjects (p = 0.012, p = 0.008, p = 0.043, and p < 0.001, respectively).

Conclusions: The RNFLT may not always increase in DON. Lamina cribrosa morphology may change in patients with TO. IV MTP therapy has a positive effect on the LCT but not on radial peripapillary capillary vascular density or LCD.

MeSH terms

  • Administration, Intravenous
  • Adult
  • Female
  • Fluorescein Angiography* / methods
  • Follow-Up Studies
  • Glucocorticoids* / administration & dosage
  • Graves Ophthalmopathy* / diagnosis
  • Graves Ophthalmopathy* / drug therapy
  • Humans
  • Intraocular Pressure / drug effects
  • Intraocular Pressure / physiology
  • Male
  • Methylprednisolone* / administration & dosage
  • Microvascular Density
  • Middle Aged
  • Nerve Fibers / pathology
  • Optic Disk* / blood supply
  • Retinal Ganglion Cells* / drug effects
  • Retinal Ganglion Cells* / pathology
  • Retinal Vessels / diagnostic imaging
  • Retinal Vessels / pathology
  • Tomography, Optical Coherence* / methods
  • Visual Acuity*
  • Visual Fields / physiology

Substances

  • Methylprednisolone
  • Glucocorticoids